Skip Navigation
Working from home

COVID-19 Information for Plan Sponsors, Brokers & Advisors

As families, businesses, and communities unite to tackle the global Coronavirus (COVID-19) pandemic, we stand together. MetLife’s Retirement & Income Solutions (RIS) team takes the health and well-being of our customers, their employees and retirees, our associates and our business partners seriously. Our strength is in our solidarity. And we’re here to help you navigate this unprecedented challenge.

Your partner for a more secure future

Every day, our customers make decisions that impact the lives and financial futures of hundreds – even thousands – of people. To say it’s an extraordinary responsibility is an understatement. And it’s even more challenging with today’s increasingly dynamic and unpredictable markets due to COVID-19.

If you have any questions or concerns during this difficult time, please do not hesitate to reach out to an RIS team member. As the situation evolves, we will continue to make any necessary adjustments to our operations and update you accordingly.


RIS Team Members

Click a link below to reach a Retirement & Income Solutions expert

-?Pension Risk Transfer

-?Stable Value

-?Lifetime Income

-?Structured Settlements

-?Specialized Benefit Resources

-?Retiree Life


Other Services

- For additional MetLife “Contact” information click here

- For login services click here

FAQs addressing the impacts of coronavirus (COVID-19)

How We're Helping

Here are some of the actions we’ve taken to help our communities, customers, and employees during this difficult time:

  • The MetLife Foundation is providing $25 million in grants to support COVID-19 global relief efforts—directed toward people with urgent needs for food, healthcare, and direct financial assistance
  • Donation of thousands of face masks, bottles of hand sanitizer, and canisters of disinfecting wipes to help those in need
  • Reinforcing claims departments to process increased volume in a timely manner

Resources to keep you informed on COVID-19